Based on our data with insulin-specific antibodies and on published reports showing that the absence of affinity maturation distinguishes RFs found in healthy individuals from RFs of RA patients, we propose that RFs of RA patients act as PR-IgM and protect their target IgG. Here, CD40LG is linked to rheumatoid arthritis.